TY - JOUR
T1 - Germ cell specific protein VASA is over-expressed in epithelial ovarian cancer and disrupts DNA damage-induced G2 checkpoint
AU - Hashimoto, Hisashi
AU - Sudo, Tamotsu
AU - Mikami, Yoshiki
AU - Otani, Mieko
AU - Takano, Masaoki
AU - Tsuda, Hiroshi
AU - Itamochi, Hiroaki
AU - Katabuchi, Hidetaka
AU - Ito, Masaharu
AU - Nishimura, Ryuichiro
PY - 2008/11
Y1 - 2008/11
N2 - Objective: Cancer cells have characteristics, such as high telomerase activity and high levels of migration activity and proliferation, which are very similar to those of germ cell lineages. In this study, we examined the expression of VASA, a germ cell lineage specific marker and evaluated its clinical significance in epithelial ovarian cancer (EOC). Methods: We investigated VASA expression in 75 EOC tissues by immunohistochemistry, correlating results with clinicopathological factors. To clarify the effects of VASA on cellular phenotypes, we compared the protein expression profiles between SKOV-3 cells stably expressing VASA (SKOV-3-VASA) and vector-control cell lines by coupling 2D fingerprinting and identification of proteins by mass spectrometry. Results: VASA expression in tumor cells was found in 21of 75 cases and was positively correlated with high age and serous histology. Significant down-regulation of 14-3-3σ was observed in SKOV-3-VASA versus control cells. Over-expression of VASA abrogates the G2 checkpoint, induced by DNA damage, by down-regulating the expression of 14-3-3σ. Conclusions: These results suggest that VASA may either play a direct role in the progression of EOC or serve as a valuable marker of tumorigenesis.
AB - Objective: Cancer cells have characteristics, such as high telomerase activity and high levels of migration activity and proliferation, which are very similar to those of germ cell lineages. In this study, we examined the expression of VASA, a germ cell lineage specific marker and evaluated its clinical significance in epithelial ovarian cancer (EOC). Methods: We investigated VASA expression in 75 EOC tissues by immunohistochemistry, correlating results with clinicopathological factors. To clarify the effects of VASA on cellular phenotypes, we compared the protein expression profiles between SKOV-3 cells stably expressing VASA (SKOV-3-VASA) and vector-control cell lines by coupling 2D fingerprinting and identification of proteins by mass spectrometry. Results: VASA expression in tumor cells was found in 21of 75 cases and was positively correlated with high age and serous histology. Significant down-regulation of 14-3-3σ was observed in SKOV-3-VASA versus control cells. Over-expression of VASA abrogates the G2 checkpoint, induced by DNA damage, by down-regulating the expression of 14-3-3σ. Conclusions: These results suggest that VASA may either play a direct role in the progression of EOC or serve as a valuable marker of tumorigenesis.
UR - http://www.scopus.com/inward/record.url?scp=55649095722&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=55649095722&partnerID=8YFLogxK
U2 - 10.1016/j.ygyno.2008.08.014
DO - 10.1016/j.ygyno.2008.08.014
M3 - Article
C2 - 18805576
AN - SCOPUS:55649095722
SN - 0090-8258
VL - 111
SP - 312
EP - 319
JO - Gynecologic oncology
JF - Gynecologic oncology
IS - 2
ER -
